Eleven Biotherapeutics (EBIO) Announces Effectiveness of IND Application for EBI-031; to Receive $22M Milestone Payment

Go back to Eleven Biotherapeutics (EBIO) Announces Effectiveness of IND Application for EBI-031; to Receive $22M Milestone Payment

Eleven Biotherapeutics (EBIO) Surges on $22.5M Roche Milestone Payment

July 8, 2016 8:22 AM EDT

Eleven Biotherapeutics (Nasdaq: EBIO) is surging 43% in pre-open trade after the company announced that... More